Evidence map›Paper›PMID 35500222›Full record

ArticleBlood advances2022

Interaction between maternal killer immunoglobulin-like receptors and offspring HLAs and susceptibility of childhood ALL.

Qianxi Feng, Mi Zhou, Shaobo Li, Libby Morimoto, Helen Hansen, Swe Swe Myint, Rong Wang, Catherine Metayer, Alice Kang, Anna Lisa Fear and 8 more

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Qianxi FengCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA.ORCID 0000-0003-4888-4629
Mi ZhouDepartment of Laboratory Medicine, University of California, San Francisco, CA.
Shaobo LiCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA.ORCID 0000-0002-0544-5338
Libby MorimotoSchool of Public Health, University of California, Berkeley, CA.ORCID 0000-0002-1509-739X
Helen HansenDepartment of Neurosurgery, University of California, San Francisco, CA.ORCID 0000-0001-5456-4985
Swe Swe MyintCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA.ORCID 0000-0002-2430-088X
Rong WangDepartment of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT.
Catherine MetayerSchool of Public Health, University of California, Berkeley, CA.
Alice KangSchool of Public Health, University of California, Berkeley, CA.
Anna Lisa FearChildren's Hospital Oakland Research Institute, Oakland, CA; and.
Derek PappasChildren's Hospital Oakland Research Institute, Oakland, CA; and.
Henry ErlichChildren's Hospital Oakland Research Institute, Oakland, CA; and.
Jill A HollenbachDepartment of Neurology and Department of Epidemiology and Biostatistics, University of California, San Francisco, CA.ORCID 0000-0001-6572-7962
Nicholas MancusoCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA.ORCID 0000-0002-9352-5927
Elizabeth TrachtenbergChildren's Hospital Oakland Research Institute, Oakland, CA; and.
Adam J de SmithCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA.ORCID 0000-0003-4880-7543
Xiaomei MaDepartment of Chronic Disease Epidemiology, Yale School of Public Health, Yale University, New Haven, CT.
Joseph L WiemelsCenter for Genetic Epidemiology, Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA.ORCID 0000-0003-4838-9951
University of Southern California · USUniversity of California, Berkeley · USUniversity of California, San Francisco · USYale University · US

Funding

Perinatal immune development and risk of childhood acute lymphoblastic leukemiaR01CA175737 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MA, XIAOMEI, WIEMELS, JOSEPH LEO · 2014 to 2018
$3.0M
NCI NIH HHS R01 CA175737
6 · The paper itself

Abstract

Acute lymphoblastic leukemia (ALL) in children is associated with a distinct neonatal cytokine profile. The basis of this neonatal immune phenotype is unknown but potentially related to maternal-fetal immune receptor interactions. We conducted a case-control study of 226 case child-mother pairs and 404 control child-mother pairs to evaluate the role of interaction between HLA genotypes in the offspring and maternal killer immunoglobulin-like receptor (KIR) genotypes in the etiology of childhood ALL, while considering potential mediation by neonatal cytokines and the immune-modulating enzyme arginase-II (ARG-II). We observed different associations between offspring HLA-maternal KIR activating profiles and the risk of ALL in different predicted genetic ancestry groups. For instance, in Latino subjects who experience the highest risk of childhood leukemia, activating profiles were significantly associated with a lower risk of childhood ALL (odds ratio [OR] = 0.59; 95% confidence interval [CI], 0.49-0.71) and a higher level of ARG-II at birth (coefficient = 0.13; 95% CI, 0.04-0.22). HLA-KIR activating profiles were also associated with a lower risk of ALL in non-Latino Asians (OR = 0.63; 95% CI, 0.38-1.01), although they had a lower tumor necrosis factor-α level (coefficient = -0.27; 95% CI, -0.49 to -0.06). Among non-Latino White subjects, no significant association was observed between offspring HLA-maternal KIR interaction and ALL risk or cytokine levels. The current study reports the association between offspring HLA-maternal KIR interaction and the development of childhood ALL with variation by predicted genetic ancestry. We also observed some associations between activating profiles and immune factors related to cytokine control; however, cytokines did not demonstrate causal mediation of the activating profiles on ALL risk.

Indexed as

Killer Cells, NaturalPrecursor Cell Lymphoblastic Leukemia-LymphomaCase-Control StudiesChildCytokinesHLA AntigensHumansImmunoglobulinsReceptors, KIRCytokinesHLA AntigensImmunoglobulinsReceptors, KIR

Identifiers

PMID35500222
PMCPMC9631572
OpenAlexW4225262600

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.